Soleil Securities downgrades Hologic (Nasdaq: HOLX) from Hold to Sell ... Finally, we no longer believe the M&A premium-long a persistent theme with this stock-is warranted." To see more analyst ratings on HOLX Click Here. Hologic, Inc. …
The stock closed trading on Friday at $61.40 per share. This company is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products. Hologic Inc.’s (NASDAQ: HOLX) core …
Hologic Inc. (HOLX) reported fourth quarter EPS of $0.50 after the bell ... Hologic traded in a range for the majority of Wednesday's session and closed up by 0.04 at $39.54. The stock is now down 2.59 on 433K shares after the bell.
Hologic Inc. HOLX is slated to report third-quarter fiscal 2017 financial ... show that Hologic is likely to beat estimates this quarter. That is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 …
Canaccord maintains its buy rating on Hologic (NASDAQ: HOLX) after it announced a buyout of Gen-Probe for $3.7. Pfizer Inc. (NYSE: PFE) reported first-quarter net income fell 19% on 6.6% lower revenue. Earnings were $1.79 billion, or 24 …
NEW YORK, May 20 (Reuters) - Hologic Inc. (HOLX.O) on Sunday said it had offered $6.2 billion in cash and stock to buy Cytyc Corp. CYTC.O in hopes of creating a leading women’s health-care company. Hologic and Cytyc, which both …
Hologic, Inc. (Nasdaq: HOLX) announced the appointment of Jonathan Christodoro ... Icahn, together with his affiliates, beneficially owns approximately 34.2 million shares of Hologic common stock, which represents approximately 12.5% …
On May 23, we issued an updated research report on Bedford, MA-based Hologic Inc. HOLX – a provider of diagnostics ... Post the earnings release, the company’s share price scaled higher. The stock has rallied 7.2% compared with the …